PlainRecalls
FDA Drug Moderate Class II Terminated

Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05

Reported: October 16, 2019 Initiated: September 23, 2019 #D-0128-2020

Product Description

Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05

Reason for Recall

CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).

Details

Recalling Firm
Sandoz, Inc
Units Affected
13,130 bottles
Distribution
U.S. Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05. Recalled by Sandoz, Inc. Units affected: 13,130 bottles.
Why was this product recalled?
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Which agency issued this recall?
This recall was issued by the FDA Drug on October 16, 2019. Severity: Moderate. Recall number: D-0128-2020.